Behavioural treatments for non-epileptic attack disorder

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Brooks, Jayne L ^a   Baker, G A ^b   Goodfellow, L ^b   Bodde, N ^b   Aldenkamp, A ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NONE

Author keywords

Humans; Hypnosis methods ; Psychotherapy methods ; Quality of life; Randomized controlled trials as topic; Seizures *therapy

Indexed keywords

DIAZEPAM;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; HUMAN; HYPNOSIS; OCCUPATIONAL THERAPY; PSYCHOEDUCATION; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEIZURE; SYSTEMATIC REVIEW;

EID: 44949142246     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006370     Document Type: Review

References (69)

1. Ataoglu 2003 {published data only} Ataoglu A, Ozcetin A, Icmeli C, Ozbulut O. Paradoxical therapy in conversion reaction. Journal of Korean Medicine 2003;18:581-4.
2. Moene 2002 {published data only} Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics 2002;71(2):66-76.
3. Moene 2003 {published data only} Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis 2003;51:29-80.
4. Aboukasm 1998 Aboukasm A, Mahr G, Gahry BR, Thomas A, Barkley GL. Retrospective analysis of the effects of psychotherapeutic interventions on outcomes of psychogenic nonepileptic seizures. Epilepsia 1998;39(5):470-3.
5. Betts 1992a Betts T, Boden S. Diagnosis, management and prognosis of a group of 128 patients with non-epileptic attack disorder. Seizure 1992;1 (Part I):19-26.
6. Betts 1992b Betts T, Boden S. Diagnosis,management and prognosis of a group of 128 patients with non-epileptic attack disorder. Previous childhood sexual abuse in the aetiology of these disorders. Seizure 1992;1(Part II):27-32.
7. Bhattacharyya 1971 Bhattacharyya DD, Singh R. Behavior therapy of hysterical fits. American Journal of Psychiatry 1971;128(5):602-6.
8. Bleichhardt 2004 Bleichhardt G, Timmer B, Rief W. Cognitive-behavioural therapy for patients with multiple somatoform symptoms - a randomised controlled trial in tertiary care. Journal of Psychosomatic Research 2004;56(4):449-54.
9. Buchanan 1993 Buchanan N, Snars J. Pseudoseizures (non-epileptic attack disorder) - clinical management and outcome in 50 patients. Seizure 1993;2:141-6.
10. Chemali 2004 Chemali Z, Meadows M. The use of eye movement desensitization and reprocessing in the treatment of psychogenic seizures. Epilepsy and Behavior 2004;5(5):784-7.
11. Couprie 1995 Couprie W, Wijkicks EFM, Rooijmans HGM, van Gijn J. Outcome in conversion disorder: a follow up study. Journal of Neurology, Neurosurgery and Psychiatry 1995;58:750-2.
12. Dickes 1974 Dickes RA. Brief therapy of conversion reactions: an in-hospital technique. American Journal of Psychiatry 1974;131:584-6.
13. Dickinson 2003 Dickinson WP, Dickinson LM, deGruy FV, Main DS, Candib LM, Rost K. A randomized clinical trial of a care recommendation letter intervention for somatization in primary care. Annals of Family Medicine 2003;1(4):228-35.
14. Farias 2003 Farias ST, Thieman C, Alsaadi TM. Psychogenic nonepileptic seizures: acute change in event frequency after presentation of the diagnosis. Epilepsy & Behavior 2003;4:424-9.
15. Ford 1977 Ford CV, Long KD. Group psychotherapy of somatizing patients. Psychotherapy & Psychosomatics 1977;28(1-4):294-304.
16. Goldstein 2004 Goldstein LH, Deale AC, Mitchell-O'Malley SJ, Toone BK, Mellers JD. An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cognitive & Behavioral Neurology 2004;17(1):41-9.
17. Hellman 1990 Hellman CJ, Budd M, Borysenko J, McClelland DC, Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behavioral Medicine 1990;16(4):165-73.
18. Hiller 2003 Hiller W, Fichter MM, Rief W. A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. Journal of Psychosomatic Research 2003;54(4):369-80.
19. Jongsma 1999 Jongsma MJ, Mommers JM, Renier WO, Meinardi H. Follow-up of psychogenic, non-epileptic seizures: a pilot study-experience in a Dutch special centre for epilepsy. Seizure 1999;8:146-8.
20. Kolk 2004 Kolk AM, Schagen S, Hanewald GJ. Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patient-related predictors of change. Journal of Psychosomatic Research 2004;57(4):379-89.
21. Krull 1990 Krull F, Schifferdecker M. Inpatient treatment of conversion disorder: a clinical investigation of outcome. Psychotherapy and Psychosomatics 1990;53:161-8.
22. Larisch 2004 Larisch A, Schweickhardt A, Wirsching M, Fritzsche K. Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. Journal of Psychosomatic Research 2004;57(6):507-14.
23. Lehmann 1984 Lehmann E, Hassel P, Thorner GW, Karrass W. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam]. Fortschritte der Medizin 1984;102(40):1033-6.
24. Lempert 1990 Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. Journal of Neurology 1990;237:35-8.
25. Lidbeck 1997 Lidbeck J. Group therapy for somatization disorders in general practice: effectiveness of a short cognitive-behavioural treatment model. Acta Psychiatrica Scandinavica 1997;96(1):14-24.
26. Lyles 2003 Lyles JS, Hodges A, Collins C, Lein C, Given CW, Given B, et al. Using nurse practitioners to implement an intervention in primary care for high-utilizing patients with medically unexplained symptoms. General Hospital Psychiatry 2003;25(2):63-73.
27. McDade 1992 McDade G, Brown SW. Non-epileptic seizures: management and predictive factors of outcome. Seizure 1992;1:7-10.
28. Menza 2001 Menza M, Lauritano M, Allen L, Warman M, Ostella F, Hamer RM, et al.Treatment of somatization disorder with nefazodone: a prospective, open-label study. Annals of Clinical Psychiatry 2001;13(3):153-8.
29. Muller 2001 Muller T, Mannel M, Murck H, Rahlfs VW. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. Psychosomatic Medicine 2004;66(4):538- 47.
30. Noyes 1998 Noyes R Jr, Happel RL, Muller BA, Holt CS, Kathol RG, Sieren LR, et al.Fluvoxamine for somatoform disorders: an open trial. General Hospital Psychiatry 1998;20(6):339-44.
31. Peters 2002 Peters S, Stanley I, Rose M, Kaney S, Salmon P. A randomized controlled trial of group aerobic exercise in primary care patients with persistent, unexplained physical symptoms. Family Practice 2002;19(6):665-74.
32. Prigatano 2002 Prigatano GP, Stonnington CM, Fisher RS. Psychological factors in the genesis and management of nonepileptic seizures: clinical observations. Epilepsy & Behavior 2002;3(4):343-9.
33. Pu 1986 Pu T, Mohamed E, Iman K, El-Roey A. One hundred cases of hysteria in Eastern Libya: A socio-demographic study. British Journal of Psychiatry 1986;148:606-9.
34. Ramani 1982 Ramani V, Gumnit RJ. Management of hysterial seizures in epileptic patients. Archives of Neurology 1982;39:78-81.
35. Riaz 1998 Riaz H, Comish S, Lawton L, Scheepers B. Non-epileptic attack disorder and clinical outcome: a pilot study. Seizure 1998;7(5):365-8.
36. Rost 1994 Rost K, Kashner TM, Smith RG Jr. Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs. General Hospital Psychiatry 1994;16(6):381-9.
37. Rusch 2001 Rusch MD, Morris GL, Allen L, Lathrop L. Psychological treatment of nonepileptic events. Epilepsy & Behavior 2001;2(3):277-83.
38. Shapiro 1997 Shapiro AP, Teasell RW. Strategic-behavioural intervention in the inpatient rehabilitation of non-organic (factitious/ conversion)motor disorders. Neurorehabilitation 1997;8:183-92.
39. Shapiro 2004 Shapiro AP, Teasell W. Behavioural interventions in the rehabilitation of acute v chronic non-organic (conversion/factitious) motor disorders. British Journal of Psychiatry 2004;185:140-6.
40. Sheehan 1980 Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Archives of General Psychiatry 1980;37(1):51-9.
41. Skupin 1975 Skupin G, Franzke HG. [The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychosomatic syndromes (author's translation)]. Medizinische Klinik 1975;70(31):1279-83.
42. Smith 1986 Smith G R Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder. A randomized controlled study. New England Journal of Medicine 1986;314(22):1407-13.
43. Speckens 1995 Speckens AE, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. British Medical Journal 1995;7016:1328-32.
44. Speed 1996 Speed J.Behavioral management of conversion disorder: retrospective study. Archives of Physical Medicine and Rehabilitation 1996;77:147-54.
45. Sumathipala 2000 Sumathipala A, Hewege S, Hanwella R, Mann AH. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychological Medicine 2000;30(4):747-57.
46. Swingle 1998 Swingle PG.Neurofeedback treatment of pseudoseizure disorder. Biological psychiatry 1998;44:1196-9.
47. Volz 2000 Volz HP, Moller H.J, Reimann I, Stoll K D. Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial. European Neuropsychopharmacology 2000;10(3):211-7.
48. Volz 2003 Volz HP, Murck H, Kasper S, Moller HJ. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.[erratum appears in Psychopharmacology (Berl). 2003; 167(3):333]. Psychopharmacology 2002;164(3):294-300.
49. Wilkinson 1994 Wilkinson P, Mynors-Wallis L. Problem-solving therapy in the treatment of unexplained physical symptoms in primary care: a preliminary study. Journal of Psychosomatic Research 1994;38(6): 591-8.
50. Williams 1979 Williams DT, Gold AP, Shrout P, Shaffer D, Adams D. The impact of psychiatric intervention on patients with uncontrolled seizures. Journal of Nervous and Mental Disease 1979;167:626-31.
51. Zaroff 2004 Zaroff CM, Myers L, Barr WB, Luciano D, Devinsky O. Group psychoeducation as treatment for psychological nonepileptic seizures. Epilepsy & Behavior 2004;5(4):587-92.
52. Allen 2002 Allen LA, Escobar JI, Lehrer PM, Gara MA, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of the literature. Psychosomatic Medicine 2002;64(6):939-50.
53. Ataoglu 1998 Ataoglu A, Sir A, Ozkan, M. Paradoxical therapy in conversion disorder. Turkish Journal of Medical Sciences 1998;28:419-21.
54. Betts 1993 Betts T, Duffy N. Non-epileptic attack disorder (pseudoseizures) and sexual abuse: a review. In: GramL, JohannessenSI, OstermanPO, SillanpääM editor(s). Pseudo Epileptic Seizures. Petersfield: Wrightson Biomedical, 1993:55-65.
55. Devinsky 1998 Devinsky O. Nonepileptic psychogenic seizures: Quagmires of pathophysiology, diagnosis and treatment. Epilepsia 39;5:458-62.
56. Francis 1999a Francis P, Baker GA. Non-epileptic attack disorder (NEAD): a comprehensive review. Seizure 1999;8:53-61.
57. Francis 1999b Francis PL, Baker GA, Appleton PL. Stress and avoidance in pseudoseizures: testing the assumptions. Epilepsy Research 1999;34:241-9.
58. Heminghyt 1993 Heminghyt E, Areng S, Slinning R. An eclectic approach to the treatment of pseudo-epileptic seizures. In: GramL, JohannessenSI, OstermanPO, SillanpääM editor(s). Pseudo Epileptic Seizures. Petersfield: Wrightson Biomedical, 1993:55-65.
59. Kroenke 2000 Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychotherapy & Psychosomatics 2000;69(4):205-15.
60. LaFrance 2004 LaFrance WC Jr, Devinsky O. The treatment of nonepileptic seizures: historical perspectives and future directions. Epilepsia 2004;45(Suppl 2):15-21.
61. Lesser 2003 Lesser RP. Treatment and outcome of psychogenic nonepileptic seizures. Epilepsy Currents 2003;3:198-200.
62. Martin 2003 Martin R, Bell B, Hermann B, Mennemeyer S. Non epileptic seizures and their costs: the role neuropsychology. In: Pritigano GP, Pliskin NH editor(s). Clinical Neuropsychology and Cost outcome Research: A beginning. NY USA: Psychology Press, 2003:235-58.
63. Moene 1998 Moene FC, Hoogduin K AL, van Dyck R. The inpatient treatment of patients suffering from (motor) conversion symptoms: a description of eight cases. International Journal of Clinical and Experimental Hypnosis 1998;46(2):171-90.
64. Ramani 1993 Ramani V. Review of psychiatric treatment strategies in non-epileptic seizures. In: RowanAJ, GatesJR editor(s). Non-epileptic seizures. MA, USA: Butterworth-Heinemann, 1993:259-67.
65. Reilly 1999 Reilly J, Baker GA, Rhodes J, Salmon P. The association of sexual and physical abuse with somatization: characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder. Psychological Medicine 1999;29:399-406.
66. Reuber 2002 Reuber M, House AO. Treating patients with psychogenic nonepileptic seizures. Current Opinion in Neurology 2002;15:207- 11.
67. Reuber 2005 Reuber M, Howlett S, Kemp S. Psychologic treatment of patients with psychogenic nonepileptic seizures. Expert Review in Neurotherapeutics 2005;5(6):737-52.
68. Rusch 2001 Rusch MD, Morris GL, Allen L, Lathrop L. Psychological treatment of nonepileptic events. Epilepsy & behaviour 2001;2:277-83.
69. Stone 2004 Stone J, Sharpe M, Binzer M. Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics 2004;45:492-99.